ArticleAnti-cancer drugs2022

Refractory hypokalemia caused by cetuximab with advanced colorectal cancer patients: the case series and literature review.

Yun-Wang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.